PARP Inhibitors in the Management of Ovarian Cancer Guideline

PARP Inhibitors in the Management of Ovarian Cancer Guideline

Recent Updates in Gynecological CancerПодробнее

Recent Updates in Gynecological Cancer

PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation UpdateПодробнее

PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation Update

Molecular Classification of Endometrial Cancer and Targeted Therapy ConsiderationsПодробнее

Molecular Classification of Endometrial Cancer and Targeted Therapy Considerations

Modern, Molecularly Informed Therapy for Patients With Advanced Endometrial CancerПодробнее

Modern, Molecularly Informed Therapy for Patients With Advanced Endometrial Cancer

2021 FORCE | Hereditary Cancer | Cancer Risks, Screening & Prevention for ATM, CHEK2, PALB2 & MoreПодробнее

2021 FORCE | Hereditary Cancer | Cancer Risks, Screening & Prevention for ATM, CHEK2, PALB2 & More

Thomas Slavin, MD, FACMG, DABCC, Discusses the Use of the myChoice CDx for Ovarian CancerПодробнее

Thomas Slavin, MD, FACMG, DABCC, Discusses the Use of the myChoice CDx for Ovarian Cancer

Advanced Breast Cancer: Challenges in Pathways DevelopmentПодробнее

Advanced Breast Cancer: Challenges in Pathways Development

Dr. Krishnansu Tewari: Ovarian Cancers- Epithelial Tumors of the PelvisПодробнее

Dr. Krishnansu Tewari: Ovarian Cancers- Epithelial Tumors of the Pelvis

Advances in the Management of Cervical and Endometrial carcinomaПодробнее

Advances in the Management of Cervical and Endometrial carcinoma

События